Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up

Por Guerin, Mathilde, Salem, Naji, Walz, Jochen, Dermeche, Slimane, Gravis, Gwenaelle
Publicado em 2013

Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control

Por TYRAN, MARGUERITE, CHARRIER, NATHALIE, DARREON, JULIEN, MADROSZYK, ANNE, TALLET, AGNES, SALEM, NAJI
Publicado no In Vivo (2018)

Adenoviral-E2F-1 Radiosensitizes p53(wild-type) and p53(null) Human Prostate Cancer Cells

Por Nguyen, Khanh H., Hachem, Paul, Khor, Li-Yan, Salem, Naji, Hunt, Kelly K., Calkins, Peter R., Pollack, Alan
Publicado no Int J Radiat Oncol Biol Phys (2005)

Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma

Por GRAVIS, GWENAELLE, FAURE, MARJORIE, RYBIKOWSKI, STANISLAS, DERMECHE, SLIMANE, TYRAN, MARGUERITE, CALDERON, BENOIT, THOMASSIN, JEANNE, WALZ, JOCHEN, SALEM, NAJI
Publicado no Mol Clin Oncol (2015)

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

Por Pasero, Christine, Gravis, Gwenaëlle, Granjeaud, Samuel, Guerin, Mathilde, Thomassin-Piana, Jeanne, Rocchi, Palma, Salem, Naji, Walz, Jochen, Moretta, Alessandro, Olive, Daniel
Publicado no Oncotarget (2015)